EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Cardiac Glycosides as Novel Cancer Therapeutic Agents

Robert A Newman, Peiying Yang, Alison D Pawlus, Keith I Block

Molecular Interventions · 01.02.2008 · 8 (1) · 36-49

DOI: 10.1124/mi.8.1.8 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Interventions, erschienen am 01.02.2008. Verfasst von Robert A Newman und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Therapeutics and Pharmaceutical Development Center, University of Texas, M. D. Anderson Cancer Center, Houston, TX 77054, …. Die Arbeit wurde bisher 423-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The class of steroid-like compounds designated cardiac glycosides includes well-known drugs such as digoxin, digitoxin, and ouabain. Their continued efficacy in treatment of congestive heart failure and as anti-arrhythmic agents is well appreciated. Less well known, however, is the emerging role of this category of compounds in the prevention and/or treatment of proliferative diseases such as cancer. New findings within the past five years have revealed these compounds to be involved in complex cell-signal transduction mechanisms, resulting in selective control of human tumor but not normal cellular proliferation. As such, they represent a promising form of targeted cancer chemotherapy. New clinical studies of their anticancer potential as single or adjuvant treatments may provide insight into these potentially valuable therapeutic options. This review focuses on recent findings on cellular pharmacology of cardiac glycosides as they relate to treatment of human cancer and attempts to explain why these agents have been overlooked in the past.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnimalsAntineoplastic AgentsApoptosisAutophagyCardiac GlycosidesDrug DesignGrowth InhibitorsHumansMiceNeoplasmsRatsReceptors, EstrogenSignal TransductionSodium-Potassium-Exchanging ATPaseSpecies Specificity

Substanzen

Antineoplastic AgentsCardiac GlycosidesGrowth InhibitorsReceptors, EstrogenSodium-Potassium-Exchanging ATPase

Autor:innen und Institutionen

  • Department of Experimental Therapeutics and Pharmaceutical Development Center, University of Texas, M. D. Anderson Cancer Center, Houston, TX 77054, USA. rnewman@mdanderson.org

Zitieren

APA

Newman, R. A., Yang, P., Pawlus, A. D., & Block, K. I. (2008). Cardiac Glycosides as Novel Cancer Therapeutic Agents. Molecular Interventions, 8(1), 36-49. https://doi.org/10.1124/mi.8.1.8

Vancouver

Newman RA, Yang P, Pawlus AD, Block KI. Cardiac Glycosides as Novel Cancer Therapeutic Agents. Molecular Interventions. 2008;8(1):36-49. doi:10.1124/mi.8.1.8

BibTeX
@article{Newman2008,
  author = {Newman, Robert A and Yang, Peiying and Pawlus, Alison D and Block, Keith I},
  title = {Cardiac Glycosides as Novel Cancer Therapeutic Agents},
  journal = {Molecular Interventions},
  year = {2008},
  volume = {8},
  number = {1},
  pages = {36--49},
  doi = {10.1124/mi.8.1.8}
}
Kostenlos starten →